Skip to main content
D. Colorado· 7/11/2011

Wolfe v. Aspenbio Pharma, Inc.

Citations

  • 275 F.R.D. 625
  • 2011 U.S. Dist. LEXIS 75762
  • 2011 WL 2726019

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • finding typicality requirement satisfied where “both movant and members of the purported class allege that they purchased shares of AspenBio Pharma, Inc. (“AspenBio”
  • “As for the requirement that the lead plaintiff otherwise satisfy the requirements of Rule 23, only two of the four requirements of Rule 23(a)—typicality and adequacy—impact the analysis of the lead plaintiff issue.”

Source: CourtListener parenthetical corpus (CC0).

Judges: Blackburn

Read full opinion on CourtListener

Cites

4 cases in this archive are cited by this case.

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.